عربي دولي

European Union approves use Emphanx vaccine against monkey pox

{clean_title}
Al-Anbat -

Al-anbat - Hamad Alhmaisat

The European Commission has agreed to expand use of the Danish company's Bavarian Nordic vaccine to combat monkey pox.

According to Euronews, the company said in a statement, on Monday that "the approval of the monkey pox vaccine is an example of good cooperation between the company and European regulators, while such a decision usually takes 6 to 9 months.”

The commission's green light is valid in all EU member states, as well as in Iceland, Liechtenstein and Norway.

The promotion of the Emphanex vaccine as Genius in the United States, where it has been approved to combat monkey pox since 2019, makes it the only licensed vaccine for the disease.

Also, the European Medicines Authority (EMA) gave its approval Friday for the use of the Emphanex vaccine against monkey pox, which has been approved since 2013 in the European Union against human smallpox.


 
جميع الحقوق محفوظة لصحيفة الأنباط © 2010 - 2021
لا مانع من الاقتباس وإعادة النشر شريطة ذكر المصدر ( الأنباط )